Forsta Ap Fonden Novavax Inc Transaction History

Forsta Ap Fonden

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	BUY	$36.28 - $75.29 $72,560 - $150,580	2,000 New	2,000 $103,000
Q3 2021 Nov 10, 2021	SELL	$177.8 - $270.58 $2.81 Million - $4.28 Million	-15,800 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$121.0 - $257.67 $1.91 Million - $4.07 Million	15,800 New	15,800 $3.35 Million

292

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $662M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Forsta Ap Fonden, based on Form 13F filings with the SEC.

Stay updated on Forsta Ap Fonden with notifications on news.